AvantStay
United States
- West Hollywood, CA
- 16/12/2021
- Series B
- $160,000,000
AvantStay is the premier next-generation hospitality platform. We are redefining the way in which people travel, transact and invest. AvantStay delivers a highly-curated experience customized to guests’ needs, using a proprietary tech suite to power bookings, seamlessly operationalize in-field and remote management, and activate authentic and elevated consumer touchpoints. AvantStay currently operates in over 100 cities, with a drive-to-market approach, including 1,000+ premier properties across their diversified portfolio, and an AUM of more than $2B. In 2019, AvantStay became one of the initial twelve partners of Homes & Villas by Marriott International, and currently offers direct bookings on more than 60 OTAs.
- Industry Hospitality
- Website https://www.avantstay.com/
- LinkedIn https://www.linkedin.com/company/avantstay/
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)